Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective.
about
Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VIIBeneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metforminChronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.Prolonged survival and improved glycemia in BioBreeding diabetic rats after early sustained exposure to glucagon-like peptide 1Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes.Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes.Review of sitagliptin phosphate: a novel treatment for type 2 diabetes.Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice.Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker Diabetic Fatty rat - focus on amelioration of metabolic profile and tissue cytoprotective propertiesThe dipeptidyl peptidase-4 inhibitor sitagliptin protects against dyslipidemia-related kidney injury in Apolipoprotein E knockout miceNew therapeutic strategies for the treatment of type 2 diabetes mellitus based on incretins.
P2860
Q24529863-C3C47DAF-81AF-4931-8254-525E8DB16EABQ24642412-69C0BF8B-D1E6-4A48-99BB-E7901B7E62FBQ30513617-B3E9EBB4-0154-4E88-9930-AB62B6CA37ECQ33901714-1EEA4EC1-63CD-446B-9740-0E2BDAE8BB68Q34648201-B7635AE5-1A0A-443D-95AF-94E852D38542Q35189265-A3788AF6-A228-4F62-B155-AF8468476378Q36816194-E43CC1A5-061E-4DF7-9B52-6F6D992F693EQ36854023-AF518C50-2771-483D-9130-775CAE2843A2Q37056839-831E1B2A-F4E6-4059-AD85-A8C1A0783A85Q37720797-007FA68A-0D18-45B3-BB1A-7F2BF55432D9Q41849344-DC1321AD-4D6C-44FA-93A8-A6AB4F60C409Q42078124-BEC489C6-81EB-4594-AB07-AD8D310837EB
P2860
Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Dipeptidyl peptidase IV inhibi ...... tes: a historical perspective.
@ast
Dipeptidyl peptidase IV inhibi ...... tes: a historical perspective.
@en
Dipeptidyl peptidase IV inhibi ...... tes: a historical perspective.
@nl
type
label
Dipeptidyl peptidase IV inhibi ...... tes: a historical perspective.
@ast
Dipeptidyl peptidase IV inhibi ...... tes: a historical perspective.
@en
Dipeptidyl peptidase IV inhibi ...... tes: a historical perspective.
@nl
prefLabel
Dipeptidyl peptidase IV inhibi ...... tes: a historical perspective.
@ast
Dipeptidyl peptidase IV inhibi ...... tes: a historical perspective.
@en
Dipeptidyl peptidase IV inhibi ...... tes: a historical perspective.
@nl
P1476
Dipeptidyl peptidase IV inhibi ...... tes: a historical perspective.
@en
P356
10.1016/S0006-291X(02)00359-5
P407
P577
2002-05-01T00:00:00Z